Key result
Early ACEi or beta-blockers limit post-MI LV remodeling, improving function and reducing mortality.
Why the study?
Does early treatment with ACE inhibitors or beta-blockers prevent left ventricular remodeling and reduce mortality in patients after myocardial infarction?
Does early treatment with ACE inhibitors or beta-blockers prevent left ventricular remodeling and reduce mortality in patients after myocardial infarction?
Early intervention with ACE inhibitors or beta-blockers is crucial to attenuate left ventricular remodeling and improve prognosis following myocardial infarction.
Answers are grounded in this paper and cite their sources.
Remodeling drives post-MI HF progression; extends mechanistic understanding for targeted interventions in RCTs.
New aspects concerning cardiac remodeling after myocardial infarction. Chronic heart failure is one of the main causes of death in western countries. Heart failure contributes to the clinical symptoms of patients with cardiovascular diseases of different origins. Ventricular remodeling is the fundamental mechanism for the progression of heart failure. The remodeling includes changes in left ventricular size, shape and geometry as well as in structure and thereby leads to myocardial dysfunction. Ventricular remodeling accompanies phenotype shifts of contributing cells including hypertrophy of cardiomyocytes and changes in the interstitial collagen network causing fibrosis and myocyte slippage. Cell death due to apoptosis and necrosis seems to be involved in the process of remodeling. The progression of heart failure is related to activation of neurohumoral systems and cytokines. This activation is thought to be the major cause of remodeling and to maintain the crucial process leading to the poor prognosis. Experimental and clinical studies confirm that early treatment with angiotensin converting enzyme inhibitors or beta-blockers prevent or even limit the left ventricular remodeling after infarction with improving ventricular function and reducing the mortality. Taken together left ventricular remodeling after myocardial infarction plays the major role of progression and prognosis in developing chronic heart failure. It seems possible to reduce or delay left ventricular dysfunction by interfering with the pathophysiological process of ventricular remodeling after infarction.
No takes yet. Share an insight, caveat, or question.
Fuchs et al. (1999) conducted a review in Cardiac remodeling after myocardial infarction. Angiotensin converting enzyme inhibitors or beta-blockers was evaluated. Early treatment with angiotensin converting enzyme inhibitors or beta-blockers prevents or limits left ventricular remodeling after myocardial infarction, improving function and reducing mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: